Conditions: Gastric Cancer; Esophagus Cancer
Intervention: Drug: Oxaliplatin+Capecitabine+Pembrolizumab
Sponsors: Duke University; Merck Sharp & Dohme Corp.
Not yet recruiting
http://ift.tt/2AOXDGY
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Publication date: September 2017 Source: European Journal of Surgical Oncology (EJSO), Volume 43, Issue 9 http://ift.tt/2gezJ2D
-
Publication date: January–February 2018 Source: Materials Today, Volume 21, Issue 1 Author(s): David Bradley http://ift.tt/2BP...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου